Orion Biotechnology to Announce Novel Potency Data
April 2, 2019
OTTAWA, Ontario, March 28, 2019 (Newswire.com) – Orion Biotechnology Canada Ltd., today announced that it will be presenting data on the potency of OB-002, their
Global Headquarters
343 Preston Street
11th floor,
Ottawa, On K1S 1N4
CANADA
+1 343.291.1032
Switzerland
Campus Biotech
Innovation Park
Avenue de Sécheron 15
1202 Genève
SWITZERLAND
Poland
Orion Biotechnology
Life Science Park
UI Bobrzyńskiego 14
30-348 Krakôw
POLAND
